SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-001305
Filing Date
2019-02-28
Accepted
2019-02-28 15:32:33
Documents
96
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K qure-20181231x10k.htm 10-K 3896447
2 EX-3.1 qure-20181231ex314d4f79c.htm EX-3.1 167495
3 EX-10.38 qure-20181231ex1038398f9.htm EX-10.38 122045
4 EX-21.1 qure-20181231ex2116fdffe.htm EX-21.1 8353
5 EX-23.1 qure-20181231ex231367a6b.htm EX-23.1 2984
6 EX-31.1 qure-20181231ex3116f990d.htm EX-31.1 18617
7 EX-31.2 qure-20181231ex3128fd4ef.htm EX-31.2 18617
8 EX-32.1 qure-20181231ex321d79be2.htm EX-32.1 11811
  Complete submission text file 0001558370-19-001305.txt   13877799

Data Files

Seq Description Document Type Size
9 EX-101.INS qure-20181231.xml EX-101.INS 3043394
10 EX-101.SCH qure-20181231.xsd EX-101.SCH 86067
11 EX-101.CAL qure-20181231_cal.xml EX-101.CAL 81460
12 EX-101.DEF qure-20181231_def.xml EX-101.DEF 377670
13 EX-101.LAB qure-20181231_lab.xml EX-101.LAB 746987
14 EX-101.PRE qure-20181231_pre.xml EX-101.PRE 623177
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-36294 | Film No.: 19642813
SIC: 2834 Pharmaceutical Preparations